A carregar...
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing
OBJECTIVE: To determine the onset of preventive efficacy with eptinezumab in patients with migraine. BACKGROUND: Eptinezumab is a monoclonal antibody inhibiting calcitonin gene‐related peptide approved as an intravenously administered treatment for the prevention of migraine. METHODS: Patients who r...
Na minha lista:
| Publicado no: | Headache |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7756794/ https://ncbi.nlm.nih.gov/pubmed/33165938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.14007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|